Latanoprost
C26H40O5
432.60
5-Heptenoic acid, 7-[3,5-dihydroxy-2-(3-hydroxy-5-phenylpentyl)cyclopentyl]-1-methylethyl ester, [1R-[1α(Z),2β(R*),3α,5α]]-;
Isopropyl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoate [130209-82-4]
5-Heptenoic acid, 7-[3,5-dihydroxy-2-(3-hydroxy-5-phenylpentyl)cyclopentyl]-1-methylethyl ester, [1R-[1α(Z),2β(R*),3α,5α]]-;
Isopropyl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoate [130209-82-4]
DEFINITION
Latanoprost contains NLT 94.0% and NMT 102.0% of latanoprost (C26H40O5), calculated on the anhydrous and solvent-free basis.
USP REFERENCE STANDARDS FOR PURCHASE
USP Latanoprost RSUSP Latanoprost Related Compound A RS
USP Latanoprost Related Compound E RS
USP Orlistat Related Compound C RS